← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2025-08-05

Drug application

FDA Application #
ANDA212470
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUMETANIDE
Generic name
Bumetanide
Active ingredients
BUMETANIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
JUBILANT GENERICS
First approval
2025-08-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown